Cargando…
Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo
Lung cancer is a leading cause of cancer-related deaths worldwide. NOTCH3 signaling is mainly expressed in non-small cell lung carcinoma (NSCLC), and has been proposed as a therapeutic target of NSCLC. While, few agents for preventing or treating NSCLC via targeting NOTCH3 signaling are used in mode...
Autores principales: | Su, Tao, Yang, Xia, Deng, Jian-Hua, Huang, Qiu-Ju, Huang, Su-Chao, Zhang, Yan-Min, Zheng, Hong-Ming, Wang, Ying, Lu, Lin-Lin, Liu, Zhong-Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938359/ https://www.ncbi.nlm.nih.gov/pubmed/29765324 http://dx.doi.org/10.3389/fphar.2018.00434 |
Ejemplares similares
-
The Protective Effect of Evodiamine in Osteoarthritis: An In Vitro and In Vivo Study in Mice Model
por: Xian, Shuyuan, et al.
Publicado: (2022) -
Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis
por: Qiu, Jian-Ge, et al.
Publicado: (2019) -
Evodiamine Eliminates Colon Cancer Stem Cells via Suppressing Notch and Wnt Signaling
por: Kim, Hyejin, et al.
Publicado: (2019) -
Evaluation of the Cardiotoxicity of Evodiamine In Vitro and In Vivo
por: Yang, Weifeng, et al.
Publicado: (2017) -
Differences in tissue distribution ability of evodiamine and dehydroevodiamine are due to the dihedral angle of the molecule stereo-structure
por: Luo, Jie, et al.
Publicado: (2023)